|
Andrey Zarur, Ph.D., brings more than 15 years of operating and investing experience to Kodiak. Most recently, he founded, and served as CEO for, BioProcessors, a provider of high-throughput solutions for the biopharmaceutical industry. During his tenure, the company raised more than $40M in venture capital and closed significant deals with several of the world's most prominent biotechnology and pharmaceutical companies. As a General Partner at Kodiak, he focuses on the intersection of life sciences and technology. Andrey represents Kodiak on the boards of Fluxion, K-Motion Interactive and Weather Trends, and is Chairman of Allegro Diagnostics.
Prior to founding BioProcessors in 2001, Andrey served in a number of key positions in the life sciences and technology industries. Some of these included operational, executive and investor or board member for start-up companies involved in bioinformatics, genomics, medical devices, nanotechnology-derived materials and energy systems including Starlab N/V, GDI and StarSoft.
Andrey is the recipient of several prestigious academic and management awards including the 75th Anniversary Materials Research Society Award. He has authored numerous articles in peer-reviewed journals including Nature, Science, and Langmuir, and holds more than 100 issued and pending patents for products ranging from nanotechnology derived catalysts for environmental remediation to devices for drug development and alternative fuels. In addition to being on the Boards of Directors of BioProcessors, he serves on the Scientific Advisory Boards of Anecova and StemLife, and is on the Board of Infantia, a foundation dedicated to providing education and services for underprivileged children in developing countries. In addition, Andrey is a Young Global Leader and member of the Climate Change Taskforce of the World Economic Forum.
Andrey holds an M.S. and a Ph.D. in Chemical Engineering from MIT and is a Senior Lecturer at the Institute's Sloan School of Management.
|
